Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion type Assertion NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_head.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion description "[Treatment of breast cancer cells with CDK inhibitors (flavopiridol; roscovitine) enhanced the lethality of the ERBB1 inhibitor lapatinib in a synergistic fashion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_provenance.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion evidence source_evidence_literature NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_provenance.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion SIO_000772 20855960 NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_provenance.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion wasDerivedFrom befree-2016 NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_provenance.
- NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_assertion wasGeneratedBy ECO_0000203 NP840538.RA0jTEQi3dyGcma7uOv3hgd8gsyH29aq0gCfXkT-rncNk130_provenance.